Target Name: SET1 histone methyltransferase complex
NCBI ID: P16364
Review Report on SET1 histone methyltransferase complex Target / Biomarker Content of Review Report on SET1 histone methyltransferase complex Target / Biomarker
SET1 histone methyltransferase complex
Other Name(s): Histone H3K4 methylatransferase SET1 complex | COMPASS complex | SET1 complex | SET1C

The SET1 Histone Methyltransferase Complex: A Key Enzyme in Cellular Regulation

Histone methylation is a post-translational modification that plays a crucial role in the regulation of gene expression and DNA replication. The SET1 histone methyltransferase complex is a key enzyme involved in the regulation of histone methylation. This complex consists of the protein SET1 and the methyltransferase complex, which are composed of several subunits including histoneH3K4 methylatransferase (H3K4me3tRNA), SET1-containing protein (SET1), and de novo DNA methyltransferase (DNMTase). The SET1 complex plays a central role in the regulation of gene expression and has been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The SET1 histone methyltransferase complex is a protein complex that consists of four subunits: SET1, histoneH3K4 methylatransferase (H3K4me3tRNA), SET1-containing protein (SET1), and de novo DNA methyltransferase (DNMTase). The SET1 complex plays a central role in the regulation of gene expression and has been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The SET1 complex functions as a histone methyltransferase complex by modifying the histone H3K4 residue. Histone H3K4 is a key regulatory site for various transcription factors, including histone(H3K4me3tRNA), which is a subunit of the SET1 complex that is responsible for methylating the histone H3K4 residue. The H3K4me3tRNA serves as a template for the methyltransferase complex, which adds a methyl group to the H3K4 residue.

The SET1 complex has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and DNA replication. Studies have shown that the SET1 complex functions as a negative regulator of cell growth by preventing the inefficient use of resources . The complex has also been shown to play a role in the regulation of apoptosis by preventing the excessive production of cells that are no longer needed.

The SET1 complex has also been shown to play a role in the regulation of DNA replication by preventing the inappropriate insertion of DNA sequences in the genome. Studies have shown that the complex functions as a negative regulator of DNA replication by preventing the insertion of non- coding sequences in the genome.

The SET1 complex has also been shown to play a role in the regulation of gene expression by modifying the histone H3K4 residue. The H3K4me3tRNA serves as a template for the methyltransferase complex, which adds a methyl group to the H3K4 residue. to play a role in the regulation of gene expression by modifying the accessibility of the gene.

The SET1 complex has also been shown to play a role in the regulation of cellular signaling pathways by modifying the histone H3K4 residue. Studies have shown that the complex functions as a negative regulator of cellular signaling pathways by preventing the inefficient use of resources.

The potential clinical applications of the SET1 histone methyltransferase complex as a drug target or biomarker are vast. The complex has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and DNA replication. Therefore, inhibitors of the SET1 complex have been shown to be effective in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In addition to its potential clinical applications, the SET1 histone methyltransferase complex is also an attractive research tool for the study of histone methylation and its role in the regulation of cellular processes. The complex can be used as a

Protein Name: SET1 Histone Methyltransferase Complex

The "SET1 histone methyltransferase complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SET1 histone methyltransferase complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SETBP1 | SETBP1-DT | SETD1A | SETD1B | SETD2 | SETD3 | SETD4 | SETD4-AS1 | SETD5 | SETD6 | SETD7 | SETD9 | SETDB1 | SETDB2 | SETMAR | SETP14 | SETP20 | SETP22 | SETX | SEZ6 | SEZ6L | SEZ6L2 | SF1 | SF3A1 | SF3A2 | SF3A3 | SF3A3P2 | SF3B1 | SF3B2 | SF3B3 | SF3B4 | SF3B5 | SF3B6 | SFI1 | SFMBT1 | SFMBT2 | SFN | SFPQ | SFR1 | SFRP1 | SFRP2 | SFRP4 | SFRP5 | SFSWAP | SFT2D1 | SFT2D2 | SFT2D3 | SFTA1P | SFTA2 | SFTA3 | SFTPA1 | SFTPA2 | SFTPB | SFTPC | SFTPD | SFXN1 | SFXN2 | SFXN3 | SFXN4 | SFXN5 | SGCA | SGCB | SGCD | SGCE | SGCG | SGCZ | SGF29 | SGIP1 | SGK1 | SGK2 | SGK3 | SGMS1 | SGMS1-AS1 | SGMS2 | SGO1 | SGO1-AS1 | SGO2 | SGPL1 | SGPP1 | SGPP2 | SGSH | SGSM1 | SGSM2 | SGSM3 | SGTA | SGTB | SH2B1 | SH2B2 | SH2B3 | SH2D1A | SH2D1B | SH2D2A | SH2D3A | SH2D3C | SH2D4A | SH2D4B | SH2D5 | SH2D6 | SH2D7 | SH3 domain-binding protein 1